Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Holdco Nuvo Group DG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-67.49 Mil. Holdco Nuvo Group DG's Total Assets for the quarter that ended in Dec. 2023 was $3.49 Mil.
Therefore, Holdco Nuvo Group DG's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was -19.36.
The historical rank and industry rank for Holdco Nuvo Group DG's Equity-to-Asset or its related term are showing as below:
NUVO'
s Equity-to-Asset Range Over the Past 10 Years
Min: -19.36 Med: -10.33 Max: -3.47
Current: -19.36
During the past 3 years, the highest Equity to Asset Ratio of Holdco Nuvo Group DG was -3.47. The lowest was -19.36. And the median was -10.33.
NUVO's Equity-to-Asset is ranked worse than 99.19% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs NUVO: -19.36
Holdco Nuvo Group DG Equity-to-Asset Historical Data
The historical data trend for Holdco Nuvo Group DG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Holdco Nuvo Group DG Equity-to-Asset Chart
Holdco Nuvo Group DG Annual Data
Trend
Dec21
Dec22
Dec23
Equity-to-Asset
-3.47
-10.33
-19.36
Holdco Nuvo Group DG Semi-Annual Data
Dec21
Dec22
Dec23
Equity-to-Asset
-3.47
-10.33
-19.36
Competitive Comparison of Holdco Nuvo Group DG's Equity-to-Asset
For the Medical Devices subindustry, Holdco Nuvo Group DG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Holdco Nuvo Group DG's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Holdco Nuvo Group DG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Holdco Nuvo Group DG's Equity-to-Asset falls into.
Holdco Nuvo Group DG Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Holdco Nuvo Group DG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Holdco Nuvo Group DG (NAS:NUVO) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Holdco Nuvo Group DG Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Holdco Nuvo Group DG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Holdco Nuvo Group DG (Holdco Nuvo Group DG) Business Description
Holdco Nuvo Group DG Ltd is a women's health and connected pregnancy care company and has developed INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform that enables the delivery of remote non-stress tests and maternal and fetal heart rate monitoring, helping expectant mothers adhere to their prescribed care plan. It is leading the transformation from a world where pregnancy care is limited by outdated technology and barriers to accessing care to a world where data-driven, clinically relevant, actionable insights can be accessed both at home and in the clinic. INVU is composed of a hardware component (wearable), with digital signal processing and cloud analytics, and interfaces for every participant involved in pregnancy care.
Holdco Nuvo Group DG (Holdco Nuvo Group DG) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NUVO has been successfully added to your